Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized placebo-controlled multicenter study of EscharEx for debridement of venous leg ulcers
MOH_2018-12-26_003590Phase 2Completed
- Sponsor
- MediWound
- Start
- Sep 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of EscharEx in stasis ulcer (3 arms), sponsored by MediWound. Started Sep 2018; status: completed.
02
Drugs
EscharEx
03
Conditions
stasis ulcer
Beyond the preview
Go deeper on MOH_2018-12-26_003590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2018-12-26_003590.